Skip to main content
ClinicalTrials.govclosed

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

ClinicalTrials.gov study NCT07241793. IPD Sharing: NO. Countries: 1. Publications: 0.

ShareScore

28/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
16
Harmonization
8
Access
0
Reuse readiness
0
Engagement
4

Topics